The company
Aehr Test Systems
AEHR · Nasdaq
AEHR stood above a rising 150-day average in 49 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 26.6% below that average now. Life Science Tools & Research Services: 58% of its 79 stocks in an uptrend (+6 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 2
- Industry in uptrend
- 58% +6 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $126.4M
- Officials’ trades on record
- 0
- Institutions holding
- 246 (+69)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 49 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Vernon RogersExec VP of Sales & Mktg. | sold | 3,994at $143.77 | 17 Aug 2026filed 18 Aug 2026 |
| Rhea J. PosedelDirector | sold | 5,973at $140.00 | 14 Aug 2026filed 14 Aug 2026 |
| Howard T. SlayenDirector | sold | 5,700at $133.03 | 14 Aug 2026filed 14 Aug 2026 |
| Vernon RogersExec VP of Sales & Mktg. | sold | 1,000at $134.00 | 14 Aug 2026filed 18 Aug 2026 |
| Vernon RogersExec VP of Sales & Mktg. | sold | 1,000at $139.00 | 14 Aug 2026filed 18 Aug 2026 |
| Alberto SalamoneEVP, PPBI BUSINESS | sold | 4,200at $128.00 | 13 Aug 2026filed 14 Aug 2026 |
| Alberto SalamoneEVP, PPBI BUSINESS | sold | 5,472at $127.50 | 13 Aug 2026filed 14 Aug 2026 |
| Laura OliphantDirector | sold | 1,717at $133.00 | 12 Aug 2026filed 13 Aug 2026 |
| Adil EngineerChief Operating Officer | sold | 7,500at $130.95 | 12 Aug 2026filed 13 Aug 2026 |
| Adil EngineerChief Operating Officer | sold | 7,500at $131.10 | 12 Aug 2026filed 13 Aug 2026 |
| Geoffrey Gates ScottDirector | sold | 20,000at $131.51 | 12 Aug 2026filed 13 Aug 2026 |
| Rhea J. PosedelDirector | sold | 8,413at $130.00 | 12 Aug 2026filed 13 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 2,659,542$255.5M | +372,643+16.3% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 1,320,350$126.8M | +38,493+3.0% |
| D. E. Shaw & Co., Inc.added · filed 14 Aug 2026 | 1,177,421$113.1M | +835,783+244.6% |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 1,164,614$111.9M | +950,242+443.3% |
| FMR LLCreduced · filed 13 Aug 2026 | 1,006,830$96.7M | -1,135,809−53.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 966,659$92.9M | +48,783+5.3% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 875,505$84.1M | +149,794+20.6% |
| GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026 | 810,036$77.8M | -452,007−35.8% |
| JANE STREET GROUP, LLCadded · filed 14 Aug 2026 | 753,523$72.4M | +476,478+172.0% |
| JPMORGAN CHASE & COnew · filed 12 Aug 2026 | 732,547$69.6M | +732,547 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.